'Made in India' Bharat Biotech's COVID-19 vaccine Covaxin has been approved by Germany. Last year, the WHO issued an emergency use listing (EUL) for Covaxin.
COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.
‘Covaxin has been approved by Germany. The entrants will no longer need proof of vaccination as the Federal Cabinet relaxes restrictions.’
Covaxin Approval: New Insights
Walter J. Lindner, German ambassador to India, on May 26th Thursday hailed the German government for recognizing the WHO-listed Bharat Biotech’s Covid vaccine, Covaxin, for travel to the country starting June 1.Taking to Twitter, the Ambassador said: "Very happy that GER government just decided to recognize WHO-listed Covaxin for travels to GER, starting June 1! This Embassy has been pushing very actively for such decision (because of Covid-backlogs visa sections have longer waiting periods than normal, please have patience)."
The World Health Organization in November last year issued an emergency use listing (EUL) for Covaxin.
Bharat Biotech to Upgrade Covaxin Facilities
World Health Organization (WHO) suspended the supply of Bharat Biotech's Covaxin vaccine last month.
World Health Organization (WHO) suspended the supply of Bharat Biotech's Covaxin vaccine last month.
Covaxin to be Evaluated as COVID-19 Vaccine in US, Say Sources
Covaxin, India's COVID-19 vaccine, is to be evaluated as a vaccine candidate in the United States, said Bharat Biotech.
Covaxin, India's COVID-19 vaccine, is to be evaluated as a vaccine candidate in the United States, said Bharat Biotech.
Bharat Biotech Defends Covaxin's Safety Record Amidst New Study Concerns
Bharat Biotech reaffirms Covaxin's safety after a study raises concerns over rare adverse events like stroke and Guillain-Barre syndrome.
Bharat Biotech reaffirms Covaxin's safety after a study raises concerns over rare adverse events like stroke and Guillain-Barre syndrome.
